Search
for
Sort by
Research 151–180 of 1000+
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- Atypical bilateral hyperpigmented macules on the lower legs possibly due to cyclophosphamide.
- Recurrent pseudolymphomatous reaction to ear piercing: 20-year history
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Dermatologic therapy: December 1987 to December 1988
- TOC
- National scientific medical meeting 1996 abstracts
- Commensal Microbes and Hair Follicle Morphogenesis Coordinately Drive Treg Migration into Neonatal Skin
- Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium
- Avaliação do perfil fenotípico, proliferativo e secretório de células-tronco mesenquimais do tecido adiposo captadas por lipoaspiração assistida por laser
- Rectangular-patterned occipital alopecia areata: A report of three cases
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Oral Lichen Planus
- Adverse cutaneous effects of psychotropic medications
- Application of multiphoton microscopy in dermatological studies: A mini-review
- FOXO1, TGF-β Regulation and Wound Healing
- CUTANEOUS MASTOCYTOSIS IN CHILDREN: AN INDIAN EXPERIENCE
- Regulatory T cells in skin
- Cutaneous Reactions to Drugs
- Cutaneous Manifestations of Lupus Erythematosus
- YAP and TAZ are essential for basal and squamous cell carcinoma initiation
- The activin binding proteins follistatin and follistatin-related protein are differentially regulated in vitro and during cutaneous wound repair
- Chemotherapy and Cutaneous Drug Reactions
- Cutaneous Lupus Erythematosus
- Basal cell carcinoma of the scalp shows distinct features from the face in Asians
- Cutaneous lupus erythematosus
- Cutaneous complications of chemotherapeutic agents
- Defining Hair Follicles in the Age of Stem Cell Bioengineering
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract